The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there was just a study this morning in israel that those who are vaccinated don't get long covet symptoms after having a mild breakthrough in fact they have long coveted symptoms at the same rate as people who've never had covert at all
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and then also those who have mild symptomatic breakthroughs who have been vaccinated don't seem to get long covet symptoms